NFE2L2 and lung adenocarcinoma: We then semi-quantitatively examined expression of PIDD, NRF2, and the NRF2 target gene, MRP131, in 120 cases of treatment-naïve lung adenocarcinoma by immunohistochemistry (Supplemental Table S2, Fig. 5D).